Reata Pharmaceuticals (RETA) PT Raised to $194 at Citi
Tweet
Share
E-mailGet Alerts RETA Hot Sheet
Price: $172.36 --0%
Rating Summary:
6 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
6 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
Citi raised its price target on Reata Pharmaceuticals (NASDAQ: RETA) to $194.00 (from $190.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meridian Mining Plc (MNO:CN) PT Raised to GBP3.75 at BMO Capital
- Infosys Ltd. (INFO:IN) (INFY) PT Lowered to INR1,430 at UBS
- LTIMindtree Ltd (LTIM:IN) PT Lowered to INR3,620 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
